Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the beginning of 2018. Several of the CTS client forms specify list the Medical Director in the header and these forms will be updated on March 5, 2018. Check out the Communication page for a complete list of forms or by clicking the link below: Communications
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...